Clinical trials of vaccines against Mycobacterium tuberculosis are well under way and
results are starting to come in. Some of these results are not so encouraging, as exemplified …

Tuberculosis (TB) is the leading opportunistic disease and cause of death in patients with
HIV infection. In 2013 there were 1.1 million new TB/HIV co-infected cases globally …

Mycobacterium tuberculosis (Mtb) can persist in hostile intracellular microenvironments
evading immune cells and drug treatment. However, the protective cellular niches where …

Immunological priming—in the context of either prior infection or vaccination—elicits
protective responses against subsequent Mycobacterium tuberculosis (Mtb) infection …

OBJECTIVE: To investigate whether tobacco smoking increases the risk of tuberculosis (TB)
recurrence and identify factors associated with TB recurrence among adults who had …

Background Tuberculosis (TB) recurrence can be due to reinfection or relapse. The
contribution of each to TB incidence and the factors associated with recurrence are not well …

Reduced antituberculosis drug concentrations may contribute to unfavorable treatment
outcomes among HIV-infected patients with more advanced immune suppression, and few …

Importance Despite posing a significant challenge to global tuberculosis (TB) elimination
efforts, recurrent TB remains understudied due to the challenges of long-term observation …

The aim of this study was to investigate the association between diabetes mellitus (DM) and
tuberculosis (TB) relapse using the nationwide TB registry in Taiwan. We conducted a case …

Background The contribution of human immunodeficiency virus (HIV) co-infection to
tuberculosis (TB) recurrence is well established worldwide. We conducted this study to …